Vol 28, No 1 (2021)
Technology Note
Published online: 2020-12-01
First-in-human radiofrequency ablation of ventricular tachycardia performed through an Atrial Flow Regulator device
Abstract
Not available
References
- Muser D, Liang JJ, Santangeli P. Electrical storm in patients with implantable cardioverter-defibrillators: a practical overview. J Innov Card Rhythm Manag. 2017; 8(10): 2853–2861.
- Lewicki Ł, Sabiniewicz R, Siebert J, et al. Atrial flow regulator as a novel therapy for patients with chronic heart failure. Cardiol J. 2020; 27(3): 309–311.
- Paitazoglou C, Özdemir R, Pfister R, et al. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EuroIntervention. 2019; 15(5): 403–410.
